StockNews.com cut shares of Ennis (NYSE:EBF – Free Report) from a strong-buy rating to a buy rating in a report published on Wednesday morning.
Ennis Stock Performance
Shares of EBF opened at $23.78 on Wednesday. Ennis has a 52 week low of $18.88 and a 52 week high of $25.75. The firm has a market cap of $617.90 million, a price-to-earnings ratio of 14.86 and a beta of 0.40. The stock has a 50 day moving average of $23.33 and a 200-day moving average of $21.67.
Ennis Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 8th. Shareholders of record on Friday, October 11th will be issued a dividend of $0.25 per share. The ex-dividend date of this dividend is Friday, October 11th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 4.21%. Ennis’s dividend payout ratio (DPR) is 62.50%.
Institutional Trading of Ennis
Ennis Company Profile
Ennis, Inc manufactures and sells business forms and other business products in the United States. The company offers snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure sensitive products under the Ennis, Royal Business Forms, Block Graphics, 360º Custom Labels, ColorWorx, Enfusion, Uncompromised Check Solutions, VersaSeal, Ad Concepts, FormSource Limited, Star Award Ribbon Company, Witt Printing, B&D Litho, Genforms, PrintGraphics, Calibrated Forms, PrintXcel, Printegra, Forms Manufacturers, Mutual Graphics, TRI-C Business Forms, Major Business Systems, Independent Printing, Hoosier Data Forms, Hayes Graphics, Wright Business Graphics, Wright 360, Integrated Print & Graphics, the Flesh Company, Impressions Direct, and AmeriPrint brands.
Featured Stories
- Five stocks we like better than Ennis
- What is Forex and How Does it Work?
- CarMax’s Impressive Rally: What Investors Should Watch Next
- P/E Ratio Calculation: How to Assess Stocks
- MarketBeat Week in Review – 9/23 – 9/27
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for Ennis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ennis and related companies with MarketBeat.com's FREE daily email newsletter.